What is Core Laboratories's revenue?

Core Laboratories (CLB) generated $524.7M in revenue over the trailing twelve months, up 1.3% year over year.

Is Core Laboratories profitable?

Core Laboratories reported $29.0M in net income over the trailing twelve months, a 5.5% net margin.

What is Core Laboratories's earnings per share?

Core Laboratories's diluted EPS over the trailing twelve months is $0.61.

Where does Core Laboratories's income statement data come from?

Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.

Core Laboratories CLB Income Statement

Income Statement Balance Sheet Cash Flow Ratios Segments

Quarterly Annual TTM

YoY QoQ

Simplified Detailed

	Q1 '26	Q4 '25	Q3 '25	Q2 '25	Q1 '25
Total revenue	$121.8M-1.4%	$138.26M+7.0%	$134.52M+0.1%	$130.16M-0.3%	$123.59M-4.7%
Depreciation and amortization	$208K+67.7%	$61K-50.8%	$65K-48.0%	$109K-14.2%	$124K-3.1%
Other operating expenses	$645K+128%	$1.39M-64.1%	$5.59M+23.4%	$2.97M+24.1%	-$2.34M-176%
Operating income	$1.89M-57.3%	$15.83M+11.7%	$20.93M+5.7%	$15.29M-4.5%	$4.42M-48.5%
Operating margin	1.5%-2.0pp	11.5%+0.5pp	15.6%+0.8pp	11.7%-0.5pp	3.6%-3.0pp
Interest expense	$2.89M+11.1%	$2.61M-0.8%	$2.65M-14.7%	$2.71M-15.5%	$2.6M-24.0%
Income before income taxes	-$1M-155%	$13.22M+14.5%	$18.28M+9.5%	$12.58M-1.7%	$1.82M-64.7%
Income tax expense	-$251K-114%	$8.09M+98.6%	$3.75M-20.0%	$1.91M-47.0%	$1.75M+5.3%
Net income	-$789K-412%	$4.95M-33.2%	$14.24M+21.2%	$10.64M+17.8%	-$154K-105%
Net margin	-0.6%-0.5pp	3.6%-2.1pp	10.6%+1.8pp	8.2%+1.3pp	-0.1%-2.6pp
Diluted earnings per share	-$0.02—	$0.11-31.3%	$0.30+20.0%	$0.22+15.8%	$0.00-100%
Basic earnings per share	-$0.02—	$0.11-31.3%	$0.31+24.0%	$0.23+21.1%	$0.00-100%
Weighted-average shares, basic	46.1M-1.5%	46.4M-1.0%	46.3M-1.4%	46.6M-0.6%	46.8M-0.2%
General And Administrative Expense Excluding Depreciation	$14.72M+7.8%	$10.63M+17.1%	$10.69M+23.7%	$10.46M+2.0%	$13.65M+15.8%
Continuing operations (in dollars per share)	-$0.02—	$0.11-31.2%	$0.31+19.2%	$0.23+15.0%	$0-100%
Continuing operations (in dollars per share)	-$0.02—	$0.12-20.0%	$0.31+24.0%	$0.23+21.1%	$0-100%
Amortization of capitalized software and acquired intangible assets	$208K+67.7%	$61K-50.8%	$65K-48.0%	$109K-14.2%	$124K-3.1%
Depreciation	$3.56M-1.0%	$3.61M+1.9%	$3.53M-0.6%	$3.56M-2.3%	$3.59M-3.3%
Other income, net	$645K+128%	$1.39M-64.1%	$5.59M+23.4%	$2.97M+24.1%	-$2.34M-176%
Revenue From Contract With Customer Excluding Assessed Tax	$121.8M-1.4%	$138.26M+7.0%	$134.52M+0.1%	$130.16M-0.3%	$123.59M-4.7%
Weighted Average Number Of Assuming Diluted Shares Outstanding	46.1M-1.5%	47M-1.4%	47.1M-1.6%	47.4M-0.8%	46.8M-1.9%
EBIT	$1.89M-57.3%	$15.83M+11.7%	$20.93M+5.7%	$15.29M-4.5%	$4.42M-48.5%
EBITDA	$5.65M-30.5%	$19.5M+9.3%	$24.52M+4.4%	$18.96M-4.1%	$8.13M-34.5%
EBITDA	$5.65M-30.5%	$19.5M+9.3%	$24.52M+4.4%	$18.96M-4.1%	$8.13M-34.5%
EBITDA margin	4.6%-1.9pp	14.1%+0.3pp	18.2%+0.8pp	14.6%-0.6pp	6.6%-3.0pp
EBIT	$1.89M-57.3%	$15.83M+11.7%	$20.93M+5.7%	$15.29M-4.5%	$4.42M-48.5%

Chart any of these lines over time, or line them up against competitors.

Compare these in charts →

Ask your AI about Core Laboratories.

Connect your AI assistant and dig into the numbers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Core Laboratories's revenue?: Core Laboratories (CLB) generated $524.7M in revenue over the trailing twelve months, up 1.3% year over year.
Is Core Laboratories profitable?: Core Laboratories reported $29.0M in net income over the trailing twelve months, a 5.5% net margin.
What is Core Laboratories's earnings per share?: Core Laboratories's diluted EPS over the trailing twelve months is $0.61.
Where does Core Laboratories's income statement data come from?: Every line is extracted from Core Laboratories's SEC filings (10-K and 10-Q) and tagged in XBRL. Switch between quarterly, annual, and trailing-twelve-month views, or open any line for its full history and peer comparisons.